Liquidia Corporation (XETR:LT4) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul B. Manning Other companies: Candel Therapeutics, Inc. (Chair of the Board · Since at least Jul 26, 2021); Verrica Pharmaceuticals Inc. (Chairman · Since at least Jun 14, 2018); Taysha Gene Therapies, Inc. (Director · Sep 23, 2020 – Oct 31, 2022 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Perrigo Company plc (EVP & General Manager, PBM · Jun 9, 2010 – Jun 9, 2010 · Past) | Board Member · Since at least Nov 18, 2020 |
| Roger Jeffs Other companies: Axsome Therapeutics, Inc. (DIRECTOR · Since at least Nov 19, 2015); Sio Gene Therapies Inc (Director · Feb 8, 2018 – Apr 15, 2019 · Past); Albireo Pharma Inc (Director · Sep 27, 2017 – Jun 24, 2021 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); Sangamo Therapeutics, Inc. (Director · Jun 26, 2017 – Sep 7, 2018 · Past); United Therapeutics Corporation (President & Co-CEO, Director · Jan 5, 2006 – Mar 15, 2016 · Past) | Chief Executive Officer · Since at least Nov 18, 2020 |
| Arthur Kirsch Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past) | Board Member · Since at least Mar 24, 2021 |
| Michael Kaseta Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 4, 2024); Alimera Sciences Inc (Director · Mar 24, 2023 – Sep 16, 2024 · Past); Aralez Pharmaceuticals Inc (Chief Financial Officer · Nov 30, 2017 – Mar 15, 2018 · Past) | CFO and COO · Since at least Nov 30, 2020 |
| Stephen Bloch Other companies: Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Sep 24, 2015 · Past); Amicus Therapeutics Inc (Director · May 30, 2007 – Feb 11, 2009 · Past) | Chairman · Since at least Mar 24, 2021 |
| Joanna Horobin Other companies: Kymera Therapeutics, Inc. (Director · Jun 7, 2024 – Jun 7, 2024 · Past) | Director · Since at least Jun 20, 2024 |
| Damian deGoa | Director · Since at least Jun 17, 2025 |
| Dana Boyle | Chief Accounting Officer · Since at least Jul 1, 2025 |
| David Johnson | Director · Since at least May 19, 2026 |
| Harold Alterson | See Remarks · Since at least Nov 16, 2026 |
| Jason Adair | Chief Business Officer · Since at least Jul 21, 2021 |
| Katherine Rielly-Gauvin | Director · Since at least Jun 16, 2026 |
| Katie Rielly-Gauvin | Board Member · Since at least Aug 21, 2026 |
| Patrick Wallace | Director, Corporate Communications · Since at least Jan 27, 2026 |
| Rajeev Saggar | Chief Medical Officer · Since at least Jul 18, 2022 |
| Raman Singh | Board Member · Since at least Mar 24, 2021 |
| Robert A Lippe | Chief Operations Officer · Nov 30, 2023 – Nov 30, 2023 · Past |
| Russell Schundler | See Remarks · Since at least Mar 29, 2021 |
| Sanjeev Khindri | Chief Development Officer · Since at least Jan 1, 2026 |
| Sarah Krepp | Chief Human Resource Officer · Since at least Jul 1, 2025 |
| Scott Moomaw | Chief Commercial Officer · Since at least Nov 18, 2020 |
| Tushar Shah | CMO and Head of R&D · Jan 19, 2021 – Jan 16, 2022 · Past |